lorazepam and clonidine

lorazepam has been researched along with clonidine in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19903 (12.00)18.7374
1990's5 (20.00)18.2507
2000's12 (48.00)29.6817
2010's5 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrews, PR; Craik, DJ; Martin, JL1
Topliss, JG; Yoshida, F1
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY2
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Crammer, JL; Keshavan, MS1
Cerri, C; Cocco, E; Rovati, L1
Friedman, LS; Mayo-Smith, MF; Saitz, R1
de Angelis, L1
Brugioni, L; Graziina, A; Luciani, A; Serra, L1
Hiestand, DC; Howie, MB; Jopling, MW; Kelly, WB; McSweeney, TD; Romanelli, VA1
Hudson, RJ; Peterson, MD; Thomson, IR1
Baruch, EM; Deerfield, LJ; Rosenberg, MH1
Amabile, CM; Couillard, D; Norcross, ED; Simpson, KN; Stanley, KM; Worrall, CL1
Lunsford, SL; Miller, JG; Simpson, KN; Spencer, AP; Stanley, KM; Worrall, CL1
Barnes, BJ; Lunsford, SL; Miller, JG; Moeller, KE; Simpson, KN; Spencer, AP; Stanley, KM; Worrall, CL1
Caballero, J; Gonzalez-Blanco, M1
Baier, AR; Coons, EE; Fingesten, A; Ockert, DM; Volpicelli, JR1
da Silva, PS; Passos, RM; Waisberg, DR1
Cai, Y; Chen, K; Chen, Y; Lu, Z; Pan, SM; Xin, YC1

Reviews

2 review(s) available for lorazepam and clonidine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients.
    The Cochrane database of systematic reviews, 2015, Jan-06, Volume: 1

    Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Bradycardia; Clonidine; Conscious Sedation; Critical Illness; Dexmedetomidine; Humans; Lorazepam; Midazolam; Propofol; Randomized Controlled Trials as Topic; Respiration, Artificial; Selection Bias; Time Factors

2015

Trials

2 trial(s) available for lorazepam and clonidine

ArticleYear
Effect of oral clonidine premedication on anesthetic requirement, hormonal response, hemodynamics, and recovery in coronary artery bypass graft surgery patients.
    Journal of clinical anesthesia, 1996, Volume: 8, Issue:4

    Topics: Adrenergic alpha-Agonists; Anesthesia; Anesthesia Recovery Period; Clonidine; Coronary Artery Bypass; Double-Blind Method; Electrocardiography; Female; Hemodynamics; Hormones; Humans; Lorazepam; Male; Middle Aged; Preanesthetic Medication; Sufentanil

1996
A comparison of clonidine with conventional preanesthetic medication in patients undergoing coronary artery bypass grafting.
    Anesthesia and analgesia, 1998, Volume: 87, Issue:2

    Topics: Adrenergic alpha-Agonists; Aged; Analgesics, Opioid; Anesthetics, Intravenous; Clonidine; Coronary Artery Bypass; Double-Blind Method; Electroencephalography; Female; Hemodynamics; Humans; Hypnotics and Sedatives; Lorazepam; Male; Middle Aged; Morphine; Preanesthetic Medication; Sufentanil; Sympatholytics

1998

Other Studies

21 other study(ies) available for lorazepam and clonidine

ArticleYear
Functional group contributions to drug-receptor interactions.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:12

    Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship

1984
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
    Journal of medicinal chemistry, 2001, Jul-19, Volume: 44, Issue:15

    Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water

2001
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
    Journal of medicinal chemistry, 2002, Jun-20, Volume: 45, Issue:13

    Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding

2002
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5

    Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Clonidine in benzodiazepine withdrawal.
    Lancet (London, England), 1985, Jun-08, Volume: 1, Issue:8441

    Topics: Adult; Clonidine; Humans; Lorazepam; Male; Substance Withdrawal Syndrome

1985
Propranolol and clonidine in detoxification.
    The American journal of psychiatry, 1988, Volume: 145, Issue:10

    Topics: Clonidine; Humans; Lorazepam; Methadone; Opioid-Related Disorders; Propranolol; Psychomotor Agitation

1988
Alcohol withdrawal: a nationwide survey of inpatient treatment practices.
    Journal of general internal medicine, 1995, Volume: 10, Issue:9

    Topics: Adrenergic beta-Antagonists; Alcoholism; Barbiturates; Benzodiazepines; Chlordiazepoxide; Clonidine; Data Collection; Diazepam; Drug Administration Schedule; Hypnotics and Sedatives; Inpatients; Lorazepam; Oxazepam; Phenytoin; Substance Withdrawal Syndrome

1995
Effects of valproate and lorazepam on experimental anxiety: tolerance, withdrawal, and role of clonidine.
    Pharmacology, biochemistry, and behavior, 1995, Volume: 52, Issue:2

    Topics: Adrenergic alpha-Agonists; Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Clonidine; Drug Tolerance; Female; Injections, Intraperitoneal; Lorazepam; Mice; Substance Withdrawal Syndrome; Valproic Acid

1995
Sino-atrial and atrio-ventricular node dysfunction in a case of tizanidine overdose.
    Veterinary and human toxicology, 1995, Volume: 37, Issue:6

    Topics: Adult; Atrioventricular Node; Clonidine; Drug Overdose; Female; Humans; Hypnotics and Sedatives; Lorazepam; Muscle Relaxants, Central; Sinoatrial Node; Suicide, Attempted

1995
Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit: recommendations for management.
    The American journal of drug and alcohol abuse, 2003, Volume: 29, Issue:2

    Topics: Adult; Anticonvulsants; Antihypertensive Agents; Clonazepam; Clonidine; Delirium; Hospitalization; Humans; Lorazepam; Male; Phenobarbital; Practice Guidelines as Topic; Psychoses, Substance-Induced; Sodium Oxybate; Substance Withdrawal Syndrome

2003
Impact of an alcohol withdrawal syndrome practice guideline on surgical patient outcomes.
    Pharmacotherapy, 2003, Volume: 23, Issue:7

    Topics: Adolescent; Adult; Aged; Alcohol-Related Disorders; Clonidine; Ethanol; Female; Haloperidol; Humans; Length of Stay; Lorazepam; Male; Middle Aged; Pilot Projects; Postoperative Complications; Practice Guidelines as Topic; Prospective Studies; Restraint, Physical; Retrospective Studies; Severity of Illness Index; Substance Withdrawal Syndrome; Surgical Procedures, Operative

2003
Experience with an adult alcohol withdrawal syndrome practice guideline in internal medicine patients.
    Pharmacotherapy, 2005, Volume: 25, Issue:8

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Alcohol Withdrawal Delirium; Anti-Anxiety Agents; Antipsychotic Agents; Clonidine; Female; Haloperidol; Hospitals, Teaching; Humans; Internal Medicine; Length of Stay; Lorazepam; Male; Middle Aged; Pilot Projects; Practice Guidelines as Topic; Restraint, Physical; Retrospective Studies; Treatment Outcome

2005
Compliance of an institution-specific alcohol withdrawal protocol with evidence-based practice guidelines.
    Pharmacotherapy, 2006, Volume: 26, Issue:3

    Topics: Adrenergic alpha-Agonists; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Clonidine; Ethanol; Evidence-Based Medicine; Haloperidol; Humans; Lorazepam; Practice Guidelines as Topic; Substance Withdrawal Syndrome

2006
Treatment of postpartum depression with psychotic features in a patient with tropical spastic paraparesis.
    The Annals of pharmacotherapy, 2008, Volume: 42, Issue:6

    Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Benztropine; Clonidine; Depression, Postpartum; Female; Haiti; Haloperidol; Humans; Lorazepam; Paraparesis, Tropical Spastic; Parasympatholytics; Sertraline

2008
A nonopioid procedure for outpatient opioid detoxification.
    Journal of addiction medicine, 2011, Volume: 5, Issue:2

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Clonidine; Drug Therapy, Combination; Female; GABA Modulators; Heroin Dependence; Humans; Lorazepam; Male; Methylphenidate; Middle Aged; Modafinil; New York; Opioid-Related Disorders; Outpatients; Selective Serotonin Reuptake Inhibitors; Substance Abuse Treatment Centers; Trazodone; Treatment Outcome; Young Adult

2011
Withdrawal treatment with clonidine after prolonged use of chloral hydrate in a pediatric intensive care patient.
    Paediatric anaesthesia, 2011, Volume: 21, Issue:10

    Topics: Adrenergic alpha-Agonists; Analgesics, Opioid; Chloral Hydrate; Clonidine; Fentanyl; Humans; Hypnotics and Sedatives; Infant; Intensive Care, Neonatal; Lorazepam; Male; Methadone; Midazolam; Pneumonia; Respiratory Insufficiency; Substance Withdrawal Syndrome

2011